Helio Vision
Helio Vision develops a therapy for rare, fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Helio Vision Information
Helio Vision was acquired by
Aldeyra Therapeutics.
The acquisition happend on 2019-01-29.
Details of the transaction were not public
Acquirer
Geographic Data
Address:
City: Lexington
State: Massachusetts
Zip:
Country: United States
Financial Info
Stage:
seed
Raised Last:
$260k
Raised Total:$260k
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Helio Vision was founded in 2016 to develop a therapy for rare, fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The co-founders of Helio Vision, Massachusetts Eye and Ear Infirmary physicians Drs. Dean Eliott and Tomasz Stryjewski, have discovered that by using sustained intravitreal exposure to methotrexate, a medication with anti-proliferative and anti-inflammatory properties, this dreaded post-operative scarring cycle may be prevented.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2016 | Seed Round | $259.5k |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
